News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
MarketBeat Market update
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Cardinal Health Inc. (CAH) shares rose 1.70% to $235.17 on Friday, despite a generally negative trading session for the broader stock market. This gain snapped a two-day losing streak for the company, while the S&P 500 Index and Dow Jones Industrial Average both experienced …
Jason Hollar, Cardinal Health (CAH) CEO joins Yahoo Finance Executive Editor Brian Sozzi to detail how M&A strategy, specialty pharma growth, and drug volume dynamics are driving profits. Video Transcript 00:00 Speaker A Where do you want to take this business with acquisitions? 00:02 …
Sharemaestro market context Trend signal active 52 weeks +87.8% · Next-week setup positive 56.8%Cardinal Health CAH gave investors plenty to like in its fiscal fourth-quarter report this week, sending shares to a record high of $258 as Wall Street digests another earnings beat and an encouraging fiscal 2027 outlook. The Dividend Aristocrat's quarterly sales came in below …
Sharemaestro market context Trend signal active 52 weeks +87.8% · Next-week setup positive 56.8%Wellington Management Group LLP and its affiliated entities have disclosed a 6.34% beneficial ownership stake in Cardinal Health, Inc. (CAH) as of June 30, 2026. This ownership, totaling 14,860,271 shares, is primarily held on behalf of various advisory clients, explaining the shared voting and …
Cardinal Health's acquisitions of Strive Medical and AdaptHealth's diabetes business are projected to add two percentage points of growth to its Other segment in fiscal year 2027, strengthening its position in the at-home medical supplies and diabetes markets. CEO Jason Hollar highlighted the fragmented …
JPMorgan has raised its price target for Cardinal Health (CAH) to $260 from $215, while maintaining a Neutral rating on the stock. This adjustment comes amidst several other analyst updates for Cardinal Health, with firms like Evercore ISI, TD Cowen, and Deutsche Bank also …
Evercore ISI has raised its price target for Cardinal Health (CAH) to $270 from $265, while reiterating an Outperform rating on the stock. This adjustment reflects a continued positive outlook from the analyst firm on the pharmaceutical distributor. The news highlights recent analyst activity …
Deutsche Bank has updated its price target for Cardinal Health (CAH), increasing it to $261 from the previous $223, while keeping a "Hold" rating on the stock. This adjustment reflects new analyst valuations for the pharmaceutical distributor. The article also lists other recent analyst …
Cardinal Health Inc. (CAH) stock declined by 2.54% on Wednesday, closing at $234.16. This underperformance occurred on a mixed trading day where the S&P 500 Index rose, and the Dow Jones Industrial Average slightly fell. The stock's drop ended a two-day winning streak.
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. After a very strong multi year run, Cardinal Health stock is now being judged by a low overall value score and fresh questions about …
Sharemaestro market context Trend signal active 52 weeks +87.8% · Next-week setup positive 56.8%Cardinal Health (CAH) saw its stock hit a new all-time high despite mixed Q4 fiscal year results, including a revenue miss and a decline in its Global Medical Products and Distribution unit. The company's growth is being driven by its high-margin cell-and-gene-therapy logistics business, …
Keurig Dr Pepper has appointed Cardinal Health CFO Aaron Alt to its board of directors, effective August 14, 2026. Alt's extensive experience in finance and corporate transformation, including serving as CFO for three public companies, will be crucial as KDP prepares to separate into …
Handelsbanken Fonder AB increased its stake in Cardinal Health, Inc. (NYSE:CAH) by 12.5% in the second quarter, acquiring an additional 14,919 shares. This move is part of broader institutional investor activity in Cardinal Health, which has recently seen positive news including an earnings beat, …
Cardinal Health (CAH) came out with quarterly earnings of $2.91 per share, beating the Zacks Consensus Estimate of $2.42 per share. This compares to earnings of $2.08 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …
Sharemaestro market context Trend signal active 52 weeks +87.8% · Next-week setup positive 56.8%Cardinal Health's stock jumped nearly 7% after reporting better-than-expected fourth-quarter earnings and issuing an upbeat fiscal 2027 outlook. The company's CEO highlighted its growing position in cell and gene therapies, now exclusively serving nearly half of that market. Cardinal Health also expanded its share …
This article first appeared on GuruFocus. Revenue: Total company revenue for Q4 fiscal 2026 was $63.7 billion, an increase of 6% year-over-year. Gross Profit: Gross profit grew 16% to $2.6 billion in the quarter. Operating Income: Enterprise operating income was $935 million, up 30% …
Sharemaestro market context Trend signal active 52 weeks +87.8% · Next-week setup positive 56.8%Earnings To Watch: Cardinal Health (CAH) Reports Q2 Results Tomorrow Healthcare distributor and services company Cardinal Health (NYSE:CAH) will be announcing earnings results this Tuesday before market hours. Here's what to expect. Cardinal Health missed analysts' revenue expectations last quarter, reporting revenues of $60.94 …
Sharemaestro market context Trend signal active 52 weeks +87.8% · Next-week setup positive 56.8%Cardinal Health stock jumped Tuesday after the medical wholesaler's fiscal 2027 guidance handily beat Wall Street's expectations. Continue Reading
Sharemaestro market context Trend signal active 52 weeks +87.8% · Next-week setup positive 56.8%Cardinal Health, Inc. Q4 2026 Earnings Call Summary - Moby Strategic Performance and Operational Context Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap …
Sharemaestro market context Trend signal active 52 weeks +87.8% · Next-week setup positive 56.8%Key Points Interested in Cardinal Health, Inc.? Here are five stocks we like better. Cardinal Health delivered strong fiscal fourth-quarter results: Revenue rose 6% to $63.7 billion, operating income increased 30% to $935 million, and adjusted EPS climbed 40% to $2.91. Results included a …
Sharemaestro market context Trend signal active 52 weeks +87.8% · Next-week setup positive 56.8%Cardinal Health stock jumped Tuesday after the medical wholesaler's fiscal 2027 guidance handily beat Wall Street's expectations. Continue Reading
Sharemaestro market context Trend signal active 52 weeks +87.8% · Next-week setup positive 56.8%Cardinal Health reports mixed quarterly performance across its business segments as earnings get a lift from one-time tariff refunds. Continue Reading
Sharemaestro market context Trend signal active 52 weeks +87.8% · Next-week setup positive 56.8%For the quarter ended June 2026, Cardinal Health (CAH) reported revenue of $63.67 billion, up 5.8% over the same period last year. EPS came in at $2.91, compared to $2.08 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of …
Sharemaestro market context Trend signal active 52 weeks +87.8% · Next-week setup positive 56.8%Search by ticker symbol or company name and select a result to open its chart.